论文部分内容阅读
作者对1974～1980年间的193例(年龄28～95岁)肾细胞癌病人进行了血沉(ESR)和预后关系的研究.193例肾细胞癌病人中有71例发生癌转移,其中有42例转移者和112例无转移者进行了肾切除.另有18例转移者给予化疗,10例给予放疗.结果:193例病人5年存活率39%,其中有转移者5年存活率1%,无转移者63%.当ESR低于或等于、高于15mm/小时,无转移者5年存活率分别为100%和59%(P<0.001).当ESR低于或等于30mm/小时,有转移者1年存活率59%,当ESR高于30mm/小时,1年存活率14%,两者存活曲线
The authors studied the relationship between erythrocyte sedimentemia (ESR) and prognosis in 193 patients (aged 28-95 years) with renal cell carcinoma between 1974 and 1980. Among 193 patients with renal cell carcinoma, 71 had cancer metastasis, including 42 cases. Metastasis and 112 cases without metastasis were nephrectomized. Another 18 metastases were given chemotherapy and 10 were given radiotherapy. Results: The 5-year survival rate of 39% of the 193 patients was 5-year survival rate of 1% of metastatic patients. No metastases were found in 63%. When the ESR was less than or equal to, and greater than 15 mm/hr, the 5-year survival rate of non-metastatic patients was 100% and 59%, respectively (P<0.001). When ESR was less than or equal to 30 mm/hour, there were The 1-year survival rate of the metastasis is 59%. When the ESR is higher than 30 mm/hour, the 1-year survival rate is 14%.